Adam Inche, Ph.D.

Adam Inche, Ph.D.

CEO
Lentitek

Articles by Adam Inche, Ph.D.

  • Refining the molecular blueprint of in vivo CAR-T

    Thursday, June 18, 2026
    Laboratory management software can’t build a perfectly optimized construct for an in vivo CAR-T cell therapy, but it can make the lives of the scientists doing so considerably easier.